TABLE 1.
Clinical, radiological, and pathological information of 312 glioblastoma patients in this study
| Study cohort n = 312 | n | % |
|---|---|---|
| Gender | ||
| Female | 118 | 37.8 |
| Male | 194 | 62.2 |
| Age at diagnosis (y) | ||
| Mean | 50.0 | – |
| Median | 51.5 | – |
| Range | 18‐75 | – |
| Preoperative KPS score | ||
| >70 | 206 | 66.0 |
| ≤70 | 106 | 34.0 |
| Extent of resection | ||
| GTR | 165 | 52.9 |
| STR | 127 | 40.7 |
| PR | 20 | 6.4 |
| TERT promoter (n = 167) | ||
| Mutant | 93 | 55.7 |
| WT | 74 | 44.3 |
| MGMTp | ||
| Methylated (mean ≥ 12%) | 130 | 41.7 |
| Unmethylated (mean < 12%) | 182 | 58.3 |
| MGMT protein | ||
| <30% | 147 | 47.1 |
| ≥30% | 165 | 52.9 |
| PFS (mo) | ||
| Median | 9.5 | |
| Range | 1.0‐75.0 | |
| OS (mo) | ||
| Median | 20.0 | |
| Range | 1.0‐80.0 | |
Abbreviations: GTR, gross total removal; KPS, Karnofsky Performance Status; OS, overall survival; PFS, progression‐free survival; PR, partial removal; STR, subtotal removal.